中国医药健康产业股份有限公司关于向专业投资者公开发行公司债券获得注册批复的公告

Core Viewpoint - China National Pharmaceutical Group Co., Ltd. has received approval from the China Securities Regulatory Commission to publicly issue corporate bonds to professional investors, with a total face value not exceeding 2 billion yuan [1]. Group 1 - The company held its annual general meeting on May 16, 2025, where it approved the proposal for the registration of corporate bonds and short-term financing bills [1]. - The approval from the regulatory authority allows the company to issue bonds within 24 months from the date of approval [1]. - The company plans to implement the bond issuance based on the authorization from the annual general meeting and will fulfill its information disclosure obligations in a timely manner [1].